193 related articles for article (PubMed ID: 32319602)
1. TRIM22 inhibits endometrial cancer progression through the NOD2/NF‑κB signaling pathway and confers a favorable prognosis.
Zhang L; Zhang B; Wei M; Xu Z; Kong W; Deng K; Xu X; Zhang L; Ζhao X; Yan L
Int J Oncol; 2020 May; 56(5):1225-1239. PubMed ID: 32319602
[TBL] [Abstract][Full Text] [Related]
2. Variants in TRIM22 That Affect NOD2 Signaling Are Associated With Very-Early-Onset Inflammatory Bowel Disease.
Li Q; Lee CH; Peters LA; Mastropaolo LA; Thoeni C; Elkadri A; Schwerd T; Zhu J; Zhang B; Zhao Y; Hao K; Dinarzo A; Hoffman G; Kidd BA; Murchie R; Al Adham Z; Guo C; Kotlarz D; Cutz E; Walters TD; Shouval DS; Curran M; Dobrin R; Brodmerkel C; Snapper SB; Klein C; Brumell JH; Hu M; Nanan R; Snanter-Nanan B; Wong M; Le Deist F; Haddad E; Roifman CM; Deslandres C; Griffiths AM; Gaskin KJ; Uhlig HH; Schadt EE; Muise AM
Gastroenterology; 2016 May; 150(5):1196-1207. PubMed ID: 26836588
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of TRIM22 Relieves Oxygen-Glucose Deprivation/Reoxygenation-Induced Apoptosis and Inflammation Through Inhibition of NF-κB/NLRP3 Axis.
Kang C; Lu Z; Zhu G; Chen Y; Wu Y
Cell Mol Neurobiol; 2021 Mar; 41(2):341-351. PubMed ID: 32335773
[TBL] [Abstract][Full Text] [Related]
4. FOXC1‑mediated TRIM22 regulates the excessive proliferation and inflammation of fibroblast‑like synoviocytes in rheumatoid arthritis via NF‑κB signaling pathway.
Wei Y; Huang X; Ma Y; Dai L
Mol Med Rep; 2022 Oct; 26(4):. PubMed ID: 35946462
[TBL] [Abstract][Full Text] [Related]
5. TRIM22 activates NF-κB signaling in glioblastoma by accelerating the degradation of IκBα.
Ji J; Ding K; Luo T; Zhang X; Chen A; Zhang D; Li G; Thorsen F; Huang B; Li X; Wang J
Cell Death Differ; 2021 Jan; 28(1):367-381. PubMed ID: 32814880
[TBL] [Abstract][Full Text] [Related]
6. TRIM22 knockdown suppresses chronic myeloid leukemia via inhibiting PI3K/Akt/mTOR signaling pathway.
Li L; Qi Y; Ma X; Xiong G; Wang L; Bao C
Cell Biol Int; 2018 Sep; 42(9):1192-1199. PubMed ID: 29762880
[TBL] [Abstract][Full Text] [Related]
7. TRIM22 inhibits the TRAF6-stimulated NF-κB pathway by targeting TAB2 for degradation.
Qiu H; Huang F; Xiao H; Sun B; Yang R
Virol Sin; 2013 Aug; 28(4):209-15. PubMed ID: 23818111
[TBL] [Abstract][Full Text] [Related]
8. TRIM22 regulates macrophage autophagy and enhances Mycobacterium tuberculosis clearance by targeting the nuclear factor-multiplicity κB/beclin 1 pathway.
Lou J; Wang Y; Zheng X; Qiu W
J Cell Biochem; 2018 Nov; 119(11):8971-8980. PubMed ID: 30011088
[TBL] [Abstract][Full Text] [Related]
9. miR-215 Enhances HCV Replication by Targeting TRIM22 and Inactivating NF-κB Signaling.
Tian H; He Z
Yonsei Med J; 2018 Jun; 59(4):511-518. PubMed ID: 29749134
[TBL] [Abstract][Full Text] [Related]
10. TRIM22 inhibits osteosarcoma progression through destabilizing NRF2 and thus activation of ROS/AMPK/mTOR/autophagy signaling.
Liu W; Zhao Y; Wang G; Feng S; Ge X; Ye W; Wang Z; Zhu Y; Cai W; Bai J; Zhou X
Redox Biol; 2022 Jul; 53():102344. PubMed ID: 35636015
[TBL] [Abstract][Full Text] [Related]
11. Identification of tripartite motif-containing 22 (TRIM22) as a novel NF-κB activator.
Yu S; Gao B; Duan Z; Xu W; Xiong S
Biochem Biophys Res Commun; 2011 Jul; 410(2):247-51. PubMed ID: 21651891
[TBL] [Abstract][Full Text] [Related]
12. TRIM22 can activate the noncanonical NF-κB pathway by affecting IKKα.
Qiu H; Huang F; Gong J; Xiao H; Sun BL; Yang RG
J Recept Signal Transduct Res; 2015; 35(4):289-94. PubMed ID: 25510414
[TBL] [Abstract][Full Text] [Related]
13. TRIM22-Mediated Apoptosis is Associated with Bak Oligomerization in Monocytes.
Chen C; Zhao D; Fang S; Chen Q; Cheng B; Fang X; Shu Q
Sci Rep; 2017 Jan; 7():39961. PubMed ID: 28079123
[TBL] [Abstract][Full Text] [Related]
14. Aberrant KAT2A accumulations render TRIM22-low melanoma sensitive to Notch1 inhibitors via epigenetic reprogramming.
Gu X; Min W; Zeng Y; Fan N; Qian Q
J Transl Med; 2023 Jul; 21(1):443. PubMed ID: 37415153
[TBL] [Abstract][Full Text] [Related]
15. Long Noncoding RNA LINC01207 Promotes Colon Cancer Cell Proliferation and Invasion by Regulating miR-3125/TRIM22 Axis.
Liu R; Zhao W; Wang H; Wang J
Biomed Res Int; 2020; 2020():1216325. PubMed ID: 33299853
[TBL] [Abstract][Full Text] [Related]
16. Role of TRIM22 in ulcerative colitis and its underlying mechanisms.
Ye B; Lu Z
Mol Med Rep; 2022 Aug; 26(2):. PubMed ID: 35674157
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of tripartite-motif containing 22 expression in breast cancer is associated with a lack of p53-mediated induction.
Sun Y; Ho GH; Koong HN; Sivaramakrishnan G; Ang WT; Koh QM; Lin VC
Biochem Biophys Res Commun; 2013 Nov; 441(3):600-6. PubMed ID: 24183724
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of Tripartite motif-containing 22 (TRIM22)relieved the apoptosis of lens epithelial cells by suppressing the expression of TNF receptor-associated factor 6 (TRAF6).
Meng K; Fang C
Bioengineered; 2021 Dec; 12(1):7213-7222. PubMed ID: 34558381
[TBL] [Abstract][Full Text] [Related]
19. Expression of TRIM22 mRNA in chronic hepatitis C patients treated with direct-acting antiviral drugs.
Naveed M; Ali A; Sheikh N; Rafique S; Idrees M
APMIS; 2020 Apr; 128(4):326-334. PubMed ID: 31863490
[TBL] [Abstract][Full Text] [Related]
20. Efp promotes in vitro and in vivo growth of endometrial cancer cells along with the activation of nuclear factor-κB signaling.
Sato W; Ikeda K; Urano T; Abe Y; Nakasato N; Horie-Inoue K; Takeda S; Inoue S
PLoS One; 2018; 13(12):e0208351. PubMed ID: 30586414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
